# Erik Thunnissen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/erik-thunnissen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,184 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 80 |
| i10-index | 219 |
| Last Known Institution | Amsterdam University Medical Centers |
| OpenAlex ID | https://openalex.org/A5075942051 |
| ORCID iD | https://orcid.org/0000-0001-5355-8508 |
| Works | 429 |

## Researcher papers

- [International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma](https://scholariq.org/papers/international-association-for-the-study-of-lung-cancer-american-thoracic-society/)
- [Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer](https://scholariq.org/papers/integrative-genome-analyses-identify-key-somatic-driver-mutations-of-small-cell/)
- [Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology](https://scholariq.org/papers/updated-molecular-testing-guideline-for-the-selection-of-lung-cancer-patients/)
- [Management of Lung Nodules Detected by Volume CT Scanning](https://scholariq.org/papers/management-of-lung-nodules-detected-by-volume-ct-scanning/)
- [PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project](https://scholariq.org/papers/pd-l1-immunohistochemistry-comparability-study-in-real-life-clinical-samples/)
- [IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy](https://scholariq.org/papers/iaslc-multidisciplinary-recommendations-for-pathologic-assessment-of-lung-cancer/)
- [Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer](https://scholariq.org/papers/best-practices-recommendations-for-diagnostic-immunohistochemistry-in-lung/)
- [PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee](https://scholariq.org/papers/pd-l1-testing-for-lung-cancer-in-2019-perspective-from-the-iaslc-pathology/)
- [The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee](https://scholariq.org/papers/the-promises-and-challenges-of-tumor-mutation-burden-as-an-immunotherapy/)
- [Effect of Dietary Inulin Supplementation on Inflammation of Pouch Mucosa in Patients With an Ileal Pouch-Anal Anastomosis](https://scholariq.org/papers/effect-of-dietary-inulin-supplementation-on-inflammation-of-pouch-mucosa-in/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Amsterdam University Medical Centers](https://scholariq.org/institutions/amsterdam-university-medical-centers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.